FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

425461004: Levocetirizine dihydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661446011 Levocetirizine dihydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675178017 Levocetirizine dihydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3004941000052116 levocetirizindihydroklorid sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levocetirizine dihydrochloride (substance) Is a Levocetirizine (substance) false Inferred relationship Some
Levocetirizine dihydrochloride (substance) Has disposition (attribute) Histamine H1 receptor antagonist (disposition) true Inferred relationship Some
Levocetirizine dihydrochloride (substance) Is modification of (attribute) Levocetirizine (substance) true Inferred relationship Some
Levocetirizine dihydrochloride (substance) Is a Histamine H1 receptor antagonist true Inferred relationship Some
Levocetirizine dihydrochloride (substance) Is a Organic cyclic compound true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Levocetirizine dihydrochloride 5 mg oral tablet Has active ingredient False Levocetirizine dihydrochloride (substance) Inferred relationship Some
levocetirizin 2,5 mg/5 ml, oral lösning Has active ingredient False Levocetirizine dihydrochloride (substance) Inferred relationship Some
Levocetirizine dihydrochloride 5 mg oral tablet Has active ingredient False Levocetirizine dihydrochloride (substance) Inferred relationship Some 1
Levocetirizine dihydrochloride 5 mg oral tablet Has basis of strength substance (attribute) True Levocetirizine dihydrochloride (substance) Inferred relationship Some 1
Levocetirizine dihydrochloride 5 mg oral tablet Has precise active ingredient True Levocetirizine dihydrochloride (substance) Inferred relationship Some 1
Levocetirizine dihydrochloride 500 microgram/mL oral solution Has basis of strength substance (attribute) True Levocetirizine dihydrochloride (substance) Inferred relationship Some 1
Levocetirizine dihydrochloride 500 microgram/mL oral solution Has precise active ingredient True Levocetirizine dihydrochloride (substance) Inferred relationship Some 1
Product containing precisely levocetirizine dihydrochloride 5 milligram/1 milliliter conventional release oral drops (clinical drug) Has precise active ingredient True Levocetirizine dihydrochloride (substance) Inferred relationship Some 1
Product containing precisely levocetirizine dihydrochloride 5 milligram/1 milliliter conventional release oral drops (clinical drug) Has basis of strength substance (attribute) True Levocetirizine dihydrochloride (substance) Inferred relationship Some 1
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet Has precise active ingredient True Levocetirizine dihydrochloride (substance) Inferred relationship Some 2
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet Has basis of strength substance (attribute) True Levocetirizine dihydrochloride (substance) Inferred relationship Some 2
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Levocetirizine dihydrochloride (substance) Inferred relationship Some 2
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Levocetirizine dihydrochloride (substance) Inferred relationship Some 2

Reference Sets

GB English

US English

Back to Start